Although molybdenum is considered to be an essential trace metal for humans
, the knowledge about its metabolism is rather limited. The present study w
as aimed at the assessment of biokinetics following intravenous injection o
f trace amounts of Mo-95 or Mo-96 into Eve healthy volunteers. In a total o
f 11 investigations, the plasma clearance up to eight hours and the urinary
excretion for at least three days after the injection were evaluated. The
tracer concentrations were determined by proton nuclear activation analysis
in blood plasma and by thermal ionization mass spectrometry in urine sampl
es respectively. In all subjects, the plasma clearance is much faster than
expected from the literature. The data obtained for the plasma clearance of
the tracer can reasonably be fitted by a two exponential equation. The hal
f times of the fast component range between 4 and 70 minutes and for the sl
ow component between 3 and 30 hours. The urinary excretion of the injected
tracer seems also to be faster than expected and the fractions lost are hig
her for larger doses administered. For the smallest dose given, 34% of the
injected tracer were excreted within one day whereas for the four times lar
ger dose about 60% were lost. These findings on urinary excretion are in ag
reement with recently published results.